Literature DB >> 15518614

Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.

William H Sauer1, Jefferson T Baer, Jesse A Berlin, Stephen E Kimmel.   

Abstract

Angiotensin-converting enzyme (ACE) inhibitors differ in their affinity for tissue-bound ACE. It has been hypothesized that tissue ACE affinity might be responsible for some of the beneficial cardiovascular properties of ACE inhibitors. The present study examined this question and found no correlation between tissue ACE affinity and risk of first nonfatal myocardial infarction in patients who have hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518614     DOI: 10.1016/j.amjcard.2004.07.087

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.

Authors:  Dirk Skowasch; Achim Viktor; Melanie Schneider-Schmitt; Berndt Lüderitz; Georg Nickenig; Gerhard Bauriedel
Journal:  Clin Res Cardiol       Date:  2006-02-17       Impact factor: 5.460

Review 2.  Do ACE inhibitors all provide the same outcomes benefits in high-risk cardiovascular patients?

Authors:  Anu Lala; Mary Ann McLaughlin
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

3.  Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.

Authors:  Sameh Saber; Amr Mahmoud; Noha Helal; Eman El-Ahwany; Rasha Abdelghany
Journal:  Open Access Maced J Med Sci       Date:  2018-06-06

4.  Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.

Authors:  Marisa K Ames; Clarke E Atkins; Andrea C Lantis; James zum Brunnen
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-03-23       Impact factor: 1.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.